Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea
· Delayed Price · Currency is KRW 1,641,000
-39,000 (-2.32%)
At close: Dec 5, 2025
Samsung Biologics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 75,963,451 | 67,544,125 | 54,092,240 | 58,433,854 | 59,746,994 | 54,652,290 | Upgrade
|
| Market Cap Growth | 0.97% | 24.87% | -7.43% | -2.20% | 9.32% | 90.76% | Upgrade
|
| Enterprise Value | 75,225,021 | 67,525,830 | 54,470,491 | 57,778,382 | 59,669,231 | 54,358,190 | Upgrade
|
| Last Close Price | 1641000.00 | 1203851.91 | 964096.37 | 1041477.78 | 1133459.52 | 1036807.93 | Upgrade
|
| PE Ratio | 47.60 | 62.35 | 63.07 | 73.22 | 151.80 | 226.80 | Upgrade
|
| Forward PE | 40.07 | 62.18 | 60.08 | 82.37 | 112.20 | - | Upgrade
|
| PS Ratio | 13.80 | 14.85 | 14.64 | 19.47 | 38.10 | 46.92 | Upgrade
|
| PB Ratio | 6.24 | 6.19 | 5.50 | 6.50 | 11.97 | 11.88 | Upgrade
|
| P/TBV Ratio | 8.03 | 8.52 | 8.23 | 10.14 | 12.05 | 11.95 | Upgrade
|
| P/FCF Ratio | 95.97 | 189.90 | 80.60 | - | 1235.91 | 875.48 | Upgrade
|
| P/OCF Ratio | 34.29 | 40.71 | 32.46 | 61.31 | 131.43 | 270.44 | Upgrade
|
| PEG Ratio | 1.38 | 3.19 | 3.45 | 3.32 | 3.45 | - | Upgrade
|
| EV/Sales Ratio | 13.67 | 14.85 | 14.74 | 19.25 | 38.05 | 46.67 | Upgrade
|
| EV/EBITDA Ratio | 27.80 | 35.19 | 33.97 | 44.72 | 85.35 | 124.54 | Upgrade
|
| EV/EBIT Ratio | 36.97 | 51.15 | 48.91 | 58.74 | 111.05 | 185.66 | Upgrade
|
| EV/FCF Ratio | 95.03 | 189.85 | 81.16 | - | 1234.30 | 870.77 | Upgrade
|
| Debt / Equity Ratio | 0.10 | 0.14 | 0.19 | 0.28 | 0.26 | 0.17 | Upgrade
|
| Debt / EBITDA Ratio | 0.45 | 0.77 | 1.19 | 1.95 | 1.85 | 1.80 | Upgrade
|
| Debt / FCF Ratio | 1.54 | 4.18 | 2.85 | - | 26.74 | 12.57 | Upgrade
|
| Asset Turnover | 0.32 | 0.27 | 0.23 | 0.24 | 0.22 | 0.19 | Upgrade
|
| Inventory Turnover | 0.84 | 0.83 | 0.76 | 0.91 | 1.02 | 1.37 | Upgrade
|
| Quick Ratio | 0.52 | 0.35 | 0.50 | 0.76 | 1.24 | 1.45 | Upgrade
|
| Current Ratio | 1.69 | 1.43 | 1.33 | 1.54 | 2.55 | 2.97 | Upgrade
|
| Return on Equity (ROE) | 14.02% | 10.45% | 9.12% | 11.42% | 8.21% | 5.38% | Upgrade
|
| Return on Assets (ROA) | 7.34% | 4.94% | 4.27% | 5.01% | 4.67% | 2.97% | Upgrade
|
| Return on Capital (ROIC) | 10.10% | 6.84% | 5.99% | 6.91% | 5.76% | 3.52% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.80% | 9.80% | 9.40% | 7.90% | 7.80% | 5.00% | Upgrade
|
| Earnings Yield | 2.10% | 1.60% | 1.59% | 1.37% | 0.66% | 0.44% | Upgrade
|
| FCF Yield | 1.04% | 0.53% | 1.24% | -0.01% | 0.08% | 0.11% | Upgrade
|
| Buyback Yield / Dilution | - | - | -1.95% | -5.51% | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.